Matthew E. Hudgens-Haney

Matthew E. Hudgens-Haney

Auto-generated profile, based on publicly available information

Matthew E. Hudgens-Haney

Univ Texas Southwestern, Dallas, TX USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2014 in Neuroscience & Biobehavioral Reviews
Verified
Journal Article
Closed access
DFD.W. Frank
D.W. Frank
MDM. Dewitt
M. Dewitt
MHM. Hudgens-Haney
M. Hudgens-Haney
DSD.J. Schaeffer
D.J. Schaeffer
BBB.H. Ball
B.H. Ball
DSDean Sabatinelli
Dean Sabatinelli

19 August 2021 in Schizophrenia Bulletin
Verified
Journal Article
Open access
PDF file
BCBrett A Clementz
Brett A Clementz
DPDavid A Parker
David A Parker
RTRebekah L Trotti
Rebekah L Trotti
JMJennifer E McDowell
Jennifer E McDowell
SKSarah K Keedy
Sarah K Keedy
CTCarol A Tamminga
Carol A Tamminga
Current clinical phenomenological diagnosis in psychiatry neither captures biologically homologous disease entities nor allows for individualized treatment prescriptions based on neurobiology. In this report, we studied two large samples of cases with schizophrenia, schizoaffective, and bipolar I disorder with psychosis, presentations with clinical features of hallucinations, delusions, thought disorder, affective, or negative symptoms. A biomarker approach to subtyping psychosis cases (called psychosis Biotypes) captured neurobiological homology that was missed by conventional clinical diagnoses. Two samples (called “B-SNIP1” with 711 psychosis and 274 healthy persons, and the “replication sample” with 717 psychosis and 198 healthy persons) showed that 44 individual biomarkers, drawn from general cognition (BACS), motor inhibitory (stop signal), saccadic system (pro- and anti-saccades), and auditory EEG/ERP (paired-stimuli and oddball) tasks of psychosis-relevant brain functions were replicable (r’s from .96–.99) and temporally stable (r’s from .76–.95). Using numerical taxonomy (k-means clustering) with nine groups of integrated biomarker characteristics (called bio-factors) yielded three Biotypes that were virtually identical between the two samples and showed highly similar case assignments to subgroups based on cross-validations (88.5%–89%). Biotypes-1 and -2 shared poor cognition. Biotype-1 was further characterized by low neural response magnitudes, while Biotype-2 was further characterized by overactive neural responses and poor sensory motor inhibition. Biotype-3 was nearly normal on all bio-factors. Construct validation of Biotype EEG/ERP neurophysiology using measures of intrinsic neural activity and auditory steady state stimulation highlighted the robustness of these outcomes. Psychosis Biotypes may yield meaningful neurobiological targets for treatments and etiological investigations.

1 June 2015 in Schizophrenia Research
Verified
Journal Article
Closed access
JHJordan P. Hamm
Jordan P. Hamm
ABAnastasia M. Bobilev
Anastasia M. Bobilev
LHLauren K. Hayrynen
Lauren K. Hayrynen
MHMatthew E. Hudgens-Haney
Matthew E. Hudgens-Haney
WOWilliam T. Oliver
William T. Oliver
BCBrett A. Clementz
Brett A. Clementz

17 April 2017 in Psychophysiology
Verified
Journal Article
Closed access
PDF file
MHMatthew E. Hudgens‐Haney
Matthew E. Hudgens‐Haney
LELauren E. Ethridge
Lauren E. Ethridge
JKJustin B. Knight
Justin B. Knight
JMJennifer E. McDowell
Jennifer E. McDowell
SKSarah K. Keedy
Sarah K. Keedy
BCBrett A. Clementz
Brett A. Clementz

11 February 2020 in Schizophrenia Bulletin
Verified
Journal Article
Open access
PDF file
MHMatthew E Hudgens-Haney
Matthew E Hudgens-Haney
BCBrett A Clementz
Brett A Clementz
EIElena I Ivleva
Elena I Ivleva
MKMatcheri S Keshavan
Matcheri S Keshavan
GPGodfrey D Pearlson
Godfrey D Pearlson
CTCarol A Tamminga
Carol A Tamminga
The treatment of negative symptoms (NS) in psychosis represents an urgent unmet medical need given the significant functional impairment it contributes to psychosis syndromes. The lack of progress in treating NS is impacted by the lack of known pathophysiology or associated quantitative biomarkers, which could provide tools for research. This current analysis investigated potential associations between NS and an extensive battery of behavioral and brain-based biomarkers in 932 psychosis probands from the B-SNIP database. The current analyses examined associations between PANSS-defined NS and (1) cognition, (2) pro-/anti-saccades, (3) evoked and resting-state electroencephalography (EEG), (4) resting-state fMRI, and (5) tractography. Canonical correlation analyses yielded symptom-biomarker constructs separately for each biomarker modality. Biomarker modalities were integrated using canonical discriminant analysis to summarize the symptom-biomarker relationships into a “biomarker signature” for NS. Finally, distinct biomarker profiles for 2 NS domains (“diminished expression” vs “avolition/apathy”) were computed using step-wise linear regression. NS were associated with cognitive impairment, diminished EEG response amplitudes, deviant resting-state activity, and oculomotor abnormalities. While a connection between NS and poor cognition has been established, association to neurophysiology is novel, suggesting directions for future mechanistic studies. Each biomarker modality was related to NS in distinct and complex ways, giving NS a rich, interconnected fingerprint and suggesting that any one biomarker modality may not adequately capture the full spectrum of symptomology.

1 May 2018 in Schizophrenia Research
Verified
Journal Article
Closed access
MHMatthew E. Hudgens-Haney
Matthew E. Hudgens-Haney
LELauren E. Ethridge
Lauren E. Ethridge
JMJennifer E. McDowell
Jennifer E. McDowell
SKSarah K. Keedy
Sarah K. Keedy
GPGodfrey D. Pearlson
Godfrey D. Pearlson
BCBrett A. Clementz
Brett A. Clementz